Skip to content
The Biotechnology Innovation Organization (BIO) warned that new changes in federal recommendations for the childhood vaccination schedule are unscientific and put children’s health at […]
BIO warns of risks from change to CDC’s vaccine recommendations Read More »
The use of AI tools in the workplace is on the rise. This trend is equally true in the arena of patent practice. However,
Using AI In patent practice: Practical and ethical issues Read More »
The post-COVID era has been especially hard on patent lawyers working in the biopharma space. “I don’t think it’s an accident that during the
BIO IP Conference looks at academics and perceptions of IP Read More »
Patient advocates retold emotional stories of lives saved, changed—or at risk—as they discussed one of the most important factors enabling breakthroughs in fighting rare
Patient advocates urge action on PPRV to help fight rare disease Read More »
We sometimes imagine the inventor of a patent as a lone vanguard leading the charge toward innovation, but in the era of team research
Who invented what? BIO IP panel tackles joint inventorship Read More »
A researcher working in a university lab makes a discovery that could lead to a new cure. Investors who see the potential of the
Bayh-Dole at 45: Still an engine for innovation Read More »
Historically, Charlotte has been recognized as a major U.S. financial hub. Now, the city is making significant strides in another transformative sector: health care
Charlotte emerging as a global leader in health care innovation and med tech Read More »
While U.S. biotech leadership is recognized as essential for national security, states also understand the industry’s local benefits and are implementing policies designed to
BIO-CSBA report explains why and how states seek to attract biotech Read More »
When it comes to enabling new treatments for type 1 diabetes (T1D), Breakthrough T1D is an outstanding example of a patient group driving research
Breaking barriers to a cure: Patient perspectives matter in type 1 diabetes innovation Read More »
Cancer patients are suffering serious health consequences because step therapy practices enforced by pharmacy benefit managers (PBMs) are preventing timely access to essential medicines,
Oncologist warns PBM step therapy has ‘crossed a dangerous line’ Read More »
